Evidence map›Paper›PMID 37402274›Full record

ArticleAmerican journal of respiratory cell and molecular biology2023

Single-Cell RNA Sequencing Provides New Insights into Therapeutic Roles of Thyroid Hormone in Idiopathic Pulmonary Fibrosis.

Lan Wang, Zhongzheng Li, Ruyan Wan, Xin Pan, Bin Li, Huabin Zhao, Juntang Yang, Weiming Zhao, Shenghui Wang, Qiwen Wang and 8 more

Open access · hybridAbstract read
In one paragraph

Article in American journal of respiratory cell and molecular biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
10.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Inter-Organ Communication in Pulmonary Fibrosis: Systemic Modifiers of a Lung-Centered Disease.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 4 institutions in 3 countries.

Lan WangState Key Laboratory of Cell Differentiation and Regulation, and.
Zhongzheng LiState Key Laboratory of Cell Differentiation and Regulation, and.
Ruyan WanState Key Laboratory of Cell Differentiation and Regulation, and.
Xin PanState Key Laboratory of Cell Differentiation and Regulation, and.
Bin LiState Key Laboratory of Cell Differentiation and Regulation, and.
Huabin ZhaoState Key Laboratory of Cell Differentiation and Regulation, and.
Juntang YangState Key Laboratory of Cell Differentiation and Regulation, and.
Weiming ZhaoState Key Laboratory of Cell Differentiation and Regulation, and.
Shenghui WangState Key Laboratory of Cell Differentiation and Regulation, and.
Qiwen WangState Key Laboratory of Cell Differentiation and Regulation, and.
Peishuo YanState Key Laboratory of Cell Differentiation and Regulation, and.
Chi MaState Key Laboratory of Cell Differentiation and Regulation, and.
Hongmei YuanState Key Laboratory of Cell Differentiation and Regulation, and.
Mengxia ZhaoState Key Laboratory of Cell Differentiation and Regulation, and.
Ivan RosasDivision of Pulmonary, Critical Care and Sleep Medicine, Baylor College of Medicine, Houston, Texas.
Chen DingSchool of Life Sciences, Fudan University, Shanghai, China; and.
Baofa SunCollege of Life Science, Nankai University, Tianjin, China.
Guoying YuState Key Laboratory of Cell Differentiation and Regulation, and.ORCID 0000-0002-4124-1359
Institute of Molecular and Cell Biology · RUFudan University · CNBaylor College of Medicine · USNankai University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Idiopathic pulmonary fibrosis (IPF) is a progressive fatal interstitial lung disease without an effective cure. Herein, we explore the role of 3,5,3'-triiodothyronine (T

Indexed as

Idiopathic Pulmonary FibrosisAnimalsBleomycinFibroblastsFibrosisLungMiceSequence Analysis, RNAThyroid HormonesBleomycinThyroid Hormonescell-cell communicationgene regulatory networkpulmonary fibrosissingle-cell RNA-seqT3 therapy

Identifiers

PMID37402274
PMCPMC10557923
OpenAlexW4383106793

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.